Research graph
References from Islet Autoantibody Patterns Vary by Race and Ethnicity and Area Deprivation Index for Individuals at Risk for Type 1 Diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
2024 · External reference
Understanding and preventing type 1 diabetes through the unique working model of TrialNet
10.1007/s00125-017-4384-2 · 2017 · External reference
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
10.1001/jama.2013.6285 · 2013 · External reference
Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report
10.2337/dc18-2282 · 2019 · External reference
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association
10.2337/dc15-1419 · 2015 · External reference
Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study
10.2337/dc21-2612 · 2022 · External reference
Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY study
10.2337/dc16-0181 · 2016 · External reference
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
10.1056/nejmoa1902226 · 2019 · External reference
Teplizumab: a disease-modifying therapy for type 1 diabetes that preserves β-cell function
10.2337/dc23-0675 · 2023 · External reference
Teplizumab and β-cell function in newly diagnosed type 1 diabetes
10.1056/nejmoa2308743 · 2023 · External reference
Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY study
10.2337/dc21-0422 · 2022 · External reference
Factors associated with diabetic ketoacidosis at onset of type 1 diabetes among pediatric patients: a systematic review
10.1001/jamapediatrics.2022.3586 · 2022 · External reference
Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative
10.2337/cd21-0028 · 2021 · External reference
A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison
10.2337/dc20-0257 · 2021 · External reference
Trends in incidence of type 1 and type 2 diabetes among youths - selected counties and Indian reservations, United States, 2002–2015
10.15585/mmwr.mm6906a3 · 2020 · External reference
Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: results from the International Diabetes Federation Atlas, 11th edition, and the T1D Index version 3.0
10.1016/j.diabres.2025.112277 · 2025 · External reference
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia
10.1210/jc.2010-0293 · 2010 · External reference
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
10.1007/s00125-023-05877-9 · 2023 · External reference
Comparative analysis of the sensitivity, specificity, concordance, and 5-year predictive power of diabetes-related autoantibody assays
10.2337/db24-0814 · 2025 · External reference
Race and genetic ancestry in medicine — a time for reckoning with racism
10.1056/nejmms2029562 · 2021 · External reference
Making neighborhood-disadvantage metrics accessible — The Neighborhood Atlas
10.1056/nejmp1802313 · 2018 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Contrasting adult and pediatric populations in a cohort of at-risk relatives in the T1D TrialNet Pathway to Prevention study
10.2337/dc25-0192 · 2025 · External reference
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
10.1056/nejmoa1610187 · 2017 · External reference
Who is enrolling? The path to monitoring in type 1 diabetes TrialNet’s Pathway to Prevention
10.2337/dc19-0593 · 2019 · External reference
Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009
10.1001/jama.2014.3201 · 2014 · External reference
Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk
10.1007/s00125-018-4660-9 · 2018 · External reference
Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: a cross-sectional multicenter DPV analysis
10.2337/dc18-0724 · 2018 · External reference
Regional deprivation and diabetic ketoacidosis at type 1 diabetes diagnosis in children and adolescents: international comparison among 6 countries
10.1159/000543139 · 2026 · External reference
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
10.1016/s0140-6736(23)00457-9 · 2023 · External reference
Type 1 diabetes incidence in Scotland between 2006 and 2019
10.1111/dme.15069 · 2023 · External reference
Social determinants of health and diabetes: a scientific review
10.2337/dci20-0053 · 2020 · External reference
Genetics of type 1 diabetes
10.1111/pedi.12597 · 2018 · External reference
Letter: HL-A antigens and diabetes mellitus
10.1016/s0140-6736(74)90930-1 · 1974 · External reference
A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk
10.2337/dc18-0087 · 2018 · External reference
Chapter 13: mining electronic health records in the genomics era
10.1371/journal.pcbi.1002823 · 2012 · External reference
Genetic consequences of the transatlantic slave trade in the Americas
10.1016/j.ajhg.2020.06.012 · 2020 · External reference
The genetic ancestry of African Americans, Latinos, and European Americans across the United States
10.1016/j.ajhg.2014.11.010 · 2015 · External reference
